Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Cash from Financing Activities (2016 - 2018)

Armata Pharmaceuticals' Cash from Financing Activities history spans 5 years, with the latest figure at $6.1 million for Q4 2018.

  • For Q4 2018, Cash from Financing Activities rose 3055.83% year-over-year to $6.1 million; the TTM value through Dec 2018 reached $12.5 million, up 43.59%, while the annual FY2024 figure was $35.0 million, 35.25% down from the prior year.
  • Cash from Financing Activities for Q4 2018 was $6.1 million at Armata Pharmaceuticals, up from -$44000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $12.4 million in Q1 2015 and bottomed at -$8.4 million in Q2 2016.
  • The 4-year median for Cash from Financing Activities is -$30500.0 (2016), against an average of $2.4 million.
  • The largest annual shift saw Cash from Financing Activities crashed 3494.12% in 2017 before it surged 3324.39% in 2018.
  • A 4-year view of Cash from Financing Activities shows it stood at $12.4 million in 2015, then plummeted by 73.72% to $3.3 million in 2016, then crashed by 106.33% to -$206000.0 in 2017, then skyrocketed by 3055.83% to $6.1 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Cash from Financing Activities are $6.1 million (Q4 2018), -$44000.0 (Q3 2018), and -$204000.0 (Q2 2018).